Search Results 761-770 of 17497 for Retinal

  1. Loteprednol (ophthalmic route) - Side effects & dosage - Mayo Clinic

    It is also used to temporarily treat itching of the eye caused by a condition known as seasonal allergic conjunctivitis. This medicine belongs to the group of ...

  2. Publications - Nneka I. Comfere, M.D. - Mayo Clinic

    SCLEROMYXEDEMA ASSOCIATED WITH MACULAR EDEMA AND RETINAL HEMORRHAGE. Retin ... Retina. 2020 May; 40 (5):857-865. View PubMed; Juskewitch JE, Griffin JM ...

  3. Publications - Michael Jundt, M.D. - Mayo Clinic

    Ophthalmic Surg Lasers Imaging Retina. 2014 Jul-Aug; 45 (4):275-81. View PubMed. PST-20566114. Home; Publications. Fuel groundbreaking medical research! Give ...

  4. Stroke - Doctors and departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. Benjamin H ...

  5. Botox injections - Doctors & Departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. By Mayo Clinic Staff · Botox injections ...

  6. Botox injections - Doctors & Departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. By Mayo Clinic Staff · Botox injections ...

  7. Botox injections - Doctors & Departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. By Mayo Clinic Staff · Botox injections ...

  8. Stroke - Doctors and departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. Benjamin H ...

  9. Stroke - Doctors and departments - Mayo Clinic

    ... Retinal vein occlusion, CNS vasculitis, Spinal cord infarction. Show more areas of focus for Oana M. Dumitrascu, M.D.. Benjamin H ...

  10. Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients with Refractory Advanced Solid Tumors - Mayo Clinic

    Clinically relevant retinal abnormalities as per the medical history or ophthalmologic findings in the pretreatment evaluation (e.g., retinitis pigmentosa or ...